Osteoporosis treatment gap after hip fracture: data from a tertiary center in Turkey.

IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Sezin Doğan Çakır, Mustafa Yerli, Mesut Sonmez, Mine Adas
{"title":"Osteoporosis treatment gap after hip fracture: data from a tertiary center in Turkey.","authors":"Sezin Doğan Çakır, Mustafa Yerli, Mesut Sonmez, Mine Adas","doi":"10.1007/s11657-025-01584-7","DOIUrl":null,"url":null,"abstract":"<p><p>This study investigates the osteoporosis treatment gap and mortality following hip fractures in Turkey. We found that 83.1% of patients did not receive post-fracture osteoporosis treatment, with a 1-year mortality rate of 37%. Prior treatment, younger age, and parenteral medications were significant predictors of treatment adherence. These findings highlight the urgent need to address treatment gaps and improve patient outcomes.</p><p><strong>Objective: </strong>This study aimed to evaluate the osteoporosis treatment gap, mortality rates, and predictors of mortality in hip fracture patients in a tertiary center in Turkey.</p><p><strong>Methods: </strong>A retrospective analysis was conducted of 552 patients aged over 50 years who were hospitalized for hip fractures at Prof. Dr. Cemil Taşcıoglu City Hospital between January 2015 and November 2022. Data were collected from electronic medical records, including pre- and post-fracture osteoporosis treatment, treatment initiation times, bone mineral density (BMD) tests, and patient outcomes.</p><p><strong>Results: </strong>The mean age of the cohort was 80.2 years, with a predominance of female patients (65.1%). Prior to the fracture, 90.8% of patients had not received osteoporosis treatment. After the fracture, 83.1% of patients did not receive any osteoporosis medications. Of those treated, 45 patients (8.6%) started treatment within 3 months. The 1-year mortality rate was 37%, with significant predictors including age, male gender, lack of prior osteoporosis treatment, delayed treatment initiation, and short treatment duration. Only 5.6% of patients had a BMD test within the first year after the fracture, which was associated with improved treatment adherence and lower mortality.</p><p><strong>Conclusions: </strong>The study highlights a significant treatment gap for osteoporosis in hip fracture patients in Turkey. Prior treatment history, younger age, and use of parenteral therapies were strong predictors of adherence to post-fracture osteoporosis treatment. These findings emphasize the need for improved healthcare provider awareness, better treatment initiation protocols, and the implementation of Fracture Liaison Services.</p>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":"97"},"PeriodicalIF":3.1000,"publicationDate":"2025-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Osteoporosis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11657-025-01584-7","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

This study investigates the osteoporosis treatment gap and mortality following hip fractures in Turkey. We found that 83.1% of patients did not receive post-fracture osteoporosis treatment, with a 1-year mortality rate of 37%. Prior treatment, younger age, and parenteral medications were significant predictors of treatment adherence. These findings highlight the urgent need to address treatment gaps and improve patient outcomes.

Objective: This study aimed to evaluate the osteoporosis treatment gap, mortality rates, and predictors of mortality in hip fracture patients in a tertiary center in Turkey.

Methods: A retrospective analysis was conducted of 552 patients aged over 50 years who were hospitalized for hip fractures at Prof. Dr. Cemil Taşcıoglu City Hospital between January 2015 and November 2022. Data were collected from electronic medical records, including pre- and post-fracture osteoporosis treatment, treatment initiation times, bone mineral density (BMD) tests, and patient outcomes.

Results: The mean age of the cohort was 80.2 years, with a predominance of female patients (65.1%). Prior to the fracture, 90.8% of patients had not received osteoporosis treatment. After the fracture, 83.1% of patients did not receive any osteoporosis medications. Of those treated, 45 patients (8.6%) started treatment within 3 months. The 1-year mortality rate was 37%, with significant predictors including age, male gender, lack of prior osteoporosis treatment, delayed treatment initiation, and short treatment duration. Only 5.6% of patients had a BMD test within the first year after the fracture, which was associated with improved treatment adherence and lower mortality.

Conclusions: The study highlights a significant treatment gap for osteoporosis in hip fracture patients in Turkey. Prior treatment history, younger age, and use of parenteral therapies were strong predictors of adherence to post-fracture osteoporosis treatment. These findings emphasize the need for improved healthcare provider awareness, better treatment initiation protocols, and the implementation of Fracture Liaison Services.

髋部骨折后骨质疏松治疗差距:来自土耳其三级中心的数据。
本研究调查了土耳其髋部骨折后骨质疏松症治疗差距和死亡率。我们发现83.1%的患者未接受骨折后骨质疏松治疗,1年死亡率为37%。既往治疗、年龄较小和肠外用药是治疗依从性的显著预测因子。这些发现突出了解决治疗差距和改善患者预后的迫切需要。目的:本研究旨在评估土耳其一家三级医疗中心髋部骨折患者骨质疏松治疗差距、死亡率和死亡率预测因素。方法:回顾性分析2015年1月至2022年11月在Cemil博士Taşcıoglu城市医院住院治疗髋部骨折的552例50岁以上患者。从电子病历中收集数据,包括骨折前和骨折后骨质疏松症治疗、治疗开始时间、骨矿物质密度(BMD)测试和患者预后。结果:队列平均年龄为80.2岁,以女性患者为主(65.1%)。骨折前,90.8%的患者未接受骨质疏松治疗。骨折后,83.1%的患者未接受任何骨质疏松药物治疗。在接受治疗的患者中,45例(8.6%)在3个月内开始治疗。1年死亡率为37%,重要的预测因素包括年龄、男性、缺乏骨质疏松症治疗、延迟开始治疗和治疗时间短。只有5.6%的患者在骨折后的一年内进行了骨密度测试,这与提高治疗依从性和降低死亡率有关。结论:该研究强调了土耳其髋部骨折患者骨质疏松症的显著治疗差距。既往治疗史、年龄较小和使用肠外治疗是骨折后骨质疏松治疗依从性的有力预测因素。这些发现强调需要提高医疗保健提供者的意识,更好的治疗启动方案,以及实施骨折联络服务。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Archives of Osteoporosis
Archives of Osteoporosis ENDOCRINOLOGY & METABOLISMORTHOPEDICS -ORTHOPEDICS
CiteScore
5.50
自引率
10.00%
发文量
133
期刊介绍: Archives of Osteoporosis is an international multidisciplinary journal which is a joint initiative of the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA. The journal will highlight the specificities of different regions around the world concerning epidemiology, reference values for bone density and bone metabolism, as well as clinical aspects of osteoporosis and other bone diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信